LAZARD ASSET MANAGEMENT LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$430
+92.0%
55,428
+138.0%
0.00%
Q2 2023$224
+489.5%
23,291
+162.7%
0.00%
Q4 2022$38
-99.9%
8,865
-1.2%
0.00%
Q3 2022$67,000
+26.4%
8,971
+69.3%
0.00%
Q2 2022$53,000
-18.5%
5,3000.0%0.00%
Q1 2022$65,000
+44.4%
5,300
+164.7%
0.00%
Q4 2021$45,0000.0%2,002
-43.1%
0.00%
Q1 2021$45,0003,5200.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders